| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $206.0M | -28.2% |
| Cost of Revenue | $156.0M | -33.5% |
| Gross Profit | $49.9M | -3.9% |
| R&D Expense | $16.5M | -24.3% |
| SG&A Expense | $36.6M | -13.8% |
| Operating Income | -$89.7M | +4.0% |
| Interest Expense | $7.3M | +91.2% |
| Pre-tax Income | -$86.7M | +11.7% |
| Income Tax | $1.8M | -80.5% |
| Net Income | -$90.4M | +14.3% |
| EPS (Basic) | -$2.56 | +23.4% |
| EPS (Diluted) | -$2.56 | +23.4% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.7M | -50.1% |
| Accounts Receivable | $11.6M | -46.0% |
| Inventory | $33.1M | -29.0% |
| Current Assets | $82.4M | -14.3% |
| Total Assets | $86.3M | -47.2% |
| Current Liabilities | $41.4M | -23.3% |
| Total Liabilities | $110.1M | +7.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.1M | -67.5% |
| Capital Expenditures | $2.9M | -77.1% |
| Investing Cash Flow | $10.0M | +178.9% |
| Financing Cash Flow | -$12.3M | -210.6% |
| Free Cash Flow | $3.2M | -48.2% |
| Stockholders' Equity |
| -$23.8M |
| -138.8% |